Journey Medical Corp financial data

Symbol
DERM on Nasdaq
Industry
Pharmaceutical Preparations
Location
9237 E Via De Ventura Blvd., Suite 105, Scottsdale, Arizona
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 99.2 % -13.1%
Quick Ratio 22.3 % +0.32%
Debt-to-equity 451 % +14.2%
Return On Equity -32.8 % +81.7%
Return On Assets -5.96 % +83.6%
Operating Margin -3.25 % +94.4%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 11.6 M shares
Entity Public Float 12.3 M USD -53.7%
Weighted Average Number of Shares Outstanding, Basic 19.8 M shares +11%
Weighted Average Number of Shares Outstanding, Diluted 19.8 M shares +11%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 80 M USD +27.8%
Revenue from Contract with Customer, Excluding Assessed Tax 60.5 M USD -2.95%
Cost of Revenue 27 M USD -6.87%
Research and Development Expense 13.4 M USD +14.4%
Costs and Expenses 82.6 M USD -16.4%
Operating Income (Loss) -2.6 M USD +92.8%
Nonoperating Income (Expense) -1.34 M USD +40.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.94 M USD +89.8%
Income Tax Expense (Benefit) 221 K USD +251%
Net Income (Loss) Attributable to Parent -4.16 M USD +89.2%
Earnings Per Share, Basic -0.17 USD/shares +92.2%
Earnings Per Share, Diluted -0.17 USD/shares +92.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 24.1 M USD +38.7%
Accounts Receivable, after Allowance for Credit Loss, Current 9.8 M USD -64.5%
Inventory, Net 10.6 M USD -20.3%
Assets, Current 47 M USD -22.6%
Operating Lease, Right-of-Use Asset 79 K USD -52.7%
Intangible Assets, Net (Excluding Goodwill) 19.5 M USD -25.5%
Other Assets, Noncurrent 6 K USD -93.2%
Assets 66.6 M USD -30.5%
Accounts Payable, Current 15.3 M USD -64.9%
Accrued Liabilities, Current 20 M USD +15.3%
Liabilities, Current 38.9 M USD -49.4%
Operating Lease, Liability, Noncurrent 9 K USD -91.7%
Liabilities 53.6 M USD -39.3%
Retained Earnings (Accumulated Deficit) -82.8 M USD -5.29%
Stockholders' Equity Attributable to Parent 13 M USD +72.9%
Liabilities and Equity 66.6 M USD -30.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.02 M USD -425%
Net Cash Provided by (Used in) Financing Activities 1.64 M USD +3048%
Net Cash Provided by (Used in) Investing Activities -5 M USD +75%
Common Stock, Shares Authorized 50 M shares 0%
Common Stock, Shares, Issued 11.6 M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.38 M USD +42.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 24.1 M USD -7.82%
Interest Paid, Excluding Capitalized Interest, Operating Activities 267 K USD -50.1%
Deferred Tax Assets, Valuation Allowance 20.2 M USD +4.39%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 20.2 M USD -0.87%
Operating Lease, Liability 84 K USD -52.5%
Lessee, Operating Lease, Liability, to be Paid 86 K USD -54%
Operating Lease, Liability, Current 84 K USD -9.68%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9 K USD -91.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 9 K USD -91.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2 K USD -80%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9 K USD
Deferred Tax Assets, Operating Loss Carryforwards 4.38 M USD -33.2%
Deferred Federal Income Tax Expense (Benefit) -753 K USD +88.8%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 106 K USD +19%
Additional Paid in Capital 95.7 M USD +11.2%
Current State and Local Tax Expense (Benefit) 187 K USD +197%
Current Federal Tax Expense (Benefit) 34 K USD
Amortization of Intangible Assets 814 K USD -23.9%
Deferred Tax Assets, Net of Valuation Allowance 25 K USD -97.6%
Share-based Payment Arrangement, Expense 3.37 M USD -21.7%
Deferred State and Local Income Tax Expense (Benefit) -94 K USD +94.6%
Interest Expense 1.6 M USD -30%